Current and historical gross, operating and net profit margins for Novo Nordisk (NVO) over the last 10 years. The current net profit margin for Novo Nordisk (NVO) as of March 31, 2018 is 35.21%.
||Large Cap Pharmaceutical
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.